Gaurav Goyal

Employment

• University of Alabama at Birmingham

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (77)

• Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas)
  Blood 2026 DOI: 10.1182/blood.2026033049
  +Save
• Local disease control in patients with Erdheim–Chester disease treated with external beam radiation therapy
  British Journal of Haematology 2026 DOI: 10.1111/bjh.70698
  +Save
• Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma
  JCO Oncology Advances 2026 DOI: 10.1200/OA-25-00143
  +Save
• Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
  Blood Cancer Journal 2026 DOI: 10.1038/s41408-026-01523-w
  +Save
• Clinically Suspected Neurodegeneration in Histiocytic Neoplasms as Causes of Neurologic Decline
  Neurology Clinical Practice 2026 DOI: 10.1212/CPJ.0000000000200579
  +Save
• Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis
  Blood Advances 2025 DOI: 10.1182/bloodadvances.2024015659
  +Save
• The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma
  Blood Advances 2025 DOI: 10.1182/bloodadvances.2024014005
  +Save
• Molecular profiling is critical to guide MEK inhibitor use in Erdheim-Chester disease
  Leukemia 2025 DOI: 10.1038/s41375-025-02704-5
  +Save
• Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease
  Leukemia 2025 DOI: 10.1038/s41375-025-02656-w
  +Save
• Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease
  Blood 2025 DOI: 10.1182/blood.2024028032
  +Save